Identification of miR-27b as a novel signature from the mRNA profiles of adipose-derived mesenchymal stem cells involved in the tolerogenic response

PLoS One. 2013 Apr 16;8(4):e60492. doi: 10.1371/journal.pone.0060492. Print 2013.

Abstract

Adipose-derived mesenchymal stem cells (adipose-derived MSCs, ASCs) possess the ability to differentiate into multiple tissue types and have immune-modulatory properties similar to those of MSCs from other origins. However, the regulation of the MSC-elicited immune-modulatory activity by specific microRNA (miRNA) mechanisms remains unexplored. Gene expression profiling with knowledge-based functional enrichment analysis is an appropriate approach for unraveling these mechanisms. This tool can be used to examine the transcripts and miRNA regulators that differentiate the rat tolerogenic orthotopic liver transplantation (OLT; DA liver into PVG) and rejection OLT (DA liver into LEW) models. In both models, the rejection reaction was observed on postoperative day 7∼14 (rejection phase) but was overcome only by the PVG recipients. Thus, the global gene expression patterns of ASCs from spontaneously tolerant (PVG) and acute rejecting (LEW) rats in response to LPS activation were compared. In this study, we performed miRNA enrichment analysis based on the analysis of pathway, gene ontology (GO) terms and transcription factor binding site (TFBS) motif annotations. We found that the top candidate, miR-27, was specifically enriched and had the highest predicted frequency. We also identified a greater than 3-fold increase of miR-27b expression in the ASCs of tolerant recipients (DA to PVG) compared to those of rejecting recipients (DA to LEW) during the rejection phase in the rat OLT model. Furthermore, our data showed that miR-27b knockdown has a positive influence on the allosuppressive activity that inhibits T-cell proliferation. We found that miR-27 knockdown significantly induced the expression of CXCL12 in cultured ASCs and the expression of CXCL12 was responsible for the miR-27b antagomir-mediated inhibition of T-cell proliferation. These results, which through a series of comprehensive miRNA enrichment analyses, might be relevant for stem cell-based therapeutic applications in immunosuppressive function using ASCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / cytology*
  • Animals
  • CD4-Positive T-Lymphocytes / metabolism
  • Cells, Cultured
  • Female
  • Mesenchymal Stem Cells / metabolism*
  • MicroRNAs / genetics*
  • Oligonucleotides
  • RNA, Messenger / genetics*
  • RNA, Small Interfering / genetics
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • MicroRNAs
  • Oligonucleotides
  • RNA, Messenger
  • RNA, Small Interfering

Grants and funding

This work was supported in part by grants from the National Science Council (NSC101-2314-B-182A-031-MY3 to C.L. Chen; NSC101-2320-B-182-037-MY3 to T. Nakano) and the Chang Gung Memorial Hospital (CMRPG891062 and CMRPG8A0431 to C.L. Chen; CMRPG891301 to K.D. Chen; CMRPG8A0631 to K.W. Chiu) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.